Recent info on AITL (through Feb 2013)

Abstract from December 2012 American Society of Hematologists conference - AITL found to be much more common than previously recorded [in the data studied]:
https://ash.confex.com/ash/2012/webprogram/Paper50880.html

Dec 2012 "Current Concepts in T-Cell Lymphoma: Applying Evidence to Practice" - several very good downloadable powerpoints:
http://www.clinicaloptions.com/Oncology/Treatment%20Updates/T-Cell%20Lymphoma%20Concepts.aspx

 November 2012 BLOOD article "The Use of Infliximab to Control Recurrent Cytokine Storms in EBV-Associated Angioimmunoblastic Lymphoma and Hemophagocytic Syndrome"
http://abstracts.hematologylibrary.org/cgi/content/abstract/120/21/4887?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=angioimmunoblastic&searchid=1&FIRSTINDEX=0&volume=120&issue=21&resourcetype=HWCIT

November 2012 BLOOD abstract "A Targeted Mutational Landscape of Angioimmunoblastic T-Cell Lymphoma: Association Between Advanced Age and Mutations in TET2 and DNMT3A"
http://abstracts.hematologylibrary.org/cgi/content/abstract/120/21/299?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=angioimmunoblastic&searchid=1&FIRSTINDEX=0&volume=120&issue=21&resourcetype=HWCIT

 November 2012 BLOOD abstract "A Phase II Clinical Trial of Fludarabine and Cyclophosphamide Followed by Thalidomide for Angioimmunoblastic Lymphoma (AITL), an NCRI Clinical Trial. CRUK C17050/A5671"
http://abstracts.hematologylibrary.org/cgi/content/abstract/120/21/3642?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=angioimmunoblastic&searchid=1&FIRSTINDEX=0&volume=120&issue=21&resourcetype=HWCIT

November 2012 BLOOD abstract "Sobuzoxane-Containing Regimens Show Promising Response As Salvage Therapy for Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL) and Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS)"
http://abstracts.hematologylibrary.org/cgi/content/abstract/120/21/3642?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=angioimmunoblastic&searchid=1&FIRSTINDEX=0&volume=120&issue=21&resourcetype=HWCIT

November 2012 BLOOD abstract "Romidepsin Induces Durable Responses in Patients with Peripheral T-Cell Lymphoma: GPI-06–0002 Study Update"
http://abstracts.hematologylibrary.org/cgi/content/abstract/120/21/3641?sid=2cddfa51-00c2-42f5-9936-7fdb5d3c0859

November 2012 BLOOD abstract "Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE): First Detailed Report of Primary Treatment"
http://abstracts.hematologylibrary.org/cgi/content/abstract/120/21/1614?sid=2cddfa51-00c2-42f5-9936-7fdb5d3c0859

November 2012 BLOOD abstract "Preliminary Results of An Ongoing Phase I Trial of Oral Belinostat a Novel Histone Deacetylase Inhibitor in Patients with Lymphoid Malignancies"
http://abstracts.hematologylibrary.org/cgi/content/abstract/118/21/3710?sid=2cddfa51-00c2-42f5-9936-7fdb5d3c0859

August 2012 Zelenetz / CME program: Aiming for Consensus in the Treatment of T-Cell Lymphomas

http://www.medscape.org/viewarticle/768906_transcript